Managed Account Advisors’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$1.5M Sell
690
-667
-49% -$1.36M ﹤0.01% 1939
2015
Q1
$2.12M Buy
1,357
+961
+243% +$1.27M ﹤0.01% 1822
2014
Q4
$471K Buy
396
+133
+51% +$88.9K ﹤0.01% 2213
2014
Q3
$122K Sell
263
-8
-3% -$3.69K ﹤0.01% 2356
2014
Q2
$136K Sell
271
-233
-46% -$74.7K ﹤0.01% 2327
2014
Q1
$148K Buy
504
+110
+28% +$33.3K ﹤0.01% 2269
2013
Q4
$107K Buy
394
+271
+220% +$75.7K ﹤0.01% 2297
2013
Q3
$43K Buy
+123
New +$45.7K ﹤0.01% 2307

Other funds holding BLUE

Managed Account Advisors's BLUE Position: Q2 2015 in Review

Managed Account Advisors reduced its bluebird bio (BLUE) stake by 49% in Q2 2015, selling an estimated $1.36M and leaving 690 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1939.

Managed Account Advisors first reported a position in BLUE in Q3 2013 and has held it in 8 quarters since. The position peaked at $2.12M in Q1 2015. 235 funds tracked by Wall St. Rank hold BLUE as of Q2 2015.

  • Managed Account Advisors held 690 shares of bluebird bio worth $1.5M as of Q2 2015.
  • Managed Account Advisors sold 667 bluebird bio shares in Q2 2015, an estimated $1.36M.
  • bluebird bio made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1939 holding.
  • Managed Account Advisors first reported a position in bluebird bio in Q3 2013 and has held it in 8 quarters since.
  • Managed Account Advisors's bluebird bio position peaked at $2.12M in Q1 2015.
  • 235 funds tracked by Wall St. Rank held bluebird bio as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.